0.25 mg semaglutide in ml Sundae Vial 0.25mg/0.5mg Injection Wegovy® Weight Loss Injections –

Common adverse effects reported by participants who took the highest dose of retatrutide in the TRIUMPH-1 trial included nausea (42.4% of participants), diarrhoea (32.0% of participants), constipation (26.1% of participants) and vomiting (25.3% of participants)

Oral semaglutide shows weight loss of 1015%, reflecting lower bioavailability

Specialty drugs represent only about 2% of prescriptions but account for roughly half of total pharmacy spending

The following is an informational overview and does not constitute medical, health, or treatment advice

For more information, including how to opt out, see our Cookies and Pixels Policy and Privacy Policy .

In most cases where menstrual changes occur during weight loss, these settle as weight stabilises and the body adapts to its new metabolic state